4.7 Review

Recent advancements in the development of heterocyclic anti-inflammatory agents

期刊

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2020.112438

关键词

Anti-inflammatory; Pyrazole derivatives; Benzimidazole derivatives; Indole derivatives; Pyrimidine derivatives; Clinical trials

向作者/读者索取更多资源

Most of the anti-inflammatory drugs in clinical practice are becoming outdated owing to their potential side and adverse effects. These are found to be highly unsafe for long term use. Thus, since last few years, new anti-inflammatory agents are being developed and number of them are in advanced stages of clinical trials. Heterocyclic molecules have gained great attention of chemists due to their similarity to different biological precursors. In the current review, we have highlighted the recent developments (2015 onwards) in designing and synthesis of various heterocyclic anti-inflammatory molecules along with detailed SAR studies. The principal objective of this review is to provide a profound overview of the recently explored heterocyclic anti-inflammatory agents belonging to various classes such as pyrazole, pyrimidine, benzimidazole, indole, and other related heterocyclic compounds. In addition, an enlarged view on potential interactions of synthetic preparations with target inflammatory enzymes or cytokines has been provided. We have also enlisted lead compounds undergoing different clinical trials against inflammation. The elementary aim of this review is to provide restructured knowledge regarding heterocyclic molecules which will be valuable for the scientists working in the field of anti-inflammatory chemistry. The authors believe that lead compounds mentioned in the report will help to design and develop novel anti-inflammatory drug molecules targeting various factors involved in the progression of inflammation. (C) 2020 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Pharmacology & Pharmacy

A Review on the Arylpiperazine Derivatives as Potential Therapeutics for the Treatment of Various Neurological Disorders

Bhupinder Kumar, Naveen Kumar, Amandeep Thakur, Vijay Kumar, Rakesh Kumar, Vinod Kumar

Summary: Neurological disorders are related to abnormalities in neurons and the central nervous system. Current medicines only provide symptomatic relief. Arylpiperazine has been found to be an important pharmacophore in CNS active agents and can be used to design drugs for various neurological disorders.

CURRENT DRUG TARGETS (2022)

Review Food Science & Technology

Compendium of naringenin: Potential sources, analytical aspects, chemistry, nutraceutical potentials and pharmacological profile

Sukhwinder Singh, Alok Sharma, Vikramdeep Monga, Rohit Bhatia

Summary: Naringenin is an active ingredient with diverse pharmacological activities, including cardiovascular protection, neuroprotection, anti-diabetic effects, etc. It is available in various forms and formulations in the market, but further research on its bioavailability and clinical efficacy is needed.

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2023)

Review Oncology

Tivozanib: A New Hope for Treating Renal Cell Carcinoma

Indu Passi, Koushal Billowria, Bhupinder Kumar, Pooja A. Chawla

Summary: The article introduces the background of renal cell carcinoma and different types of treatment, focusing on the mechanism of action and side effects of the anti-renal cell carcinoma drug Tivozanib. Tivozanib is a highly selective and potent oral tyrosine kinase inhibitor of vascular endothelial growth factor receptors (VEGFRs), suitable for the treatment of renal cell carcinoma and can be used in combination with other drugs with minimal side effects. Further research needs to be conducted in multicenter clinical trials.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2023)

Review Chemistry, Organic

An insight on medicinal attributes of pyrimidine scaffold: An updated review

Akshun Vyas, Bhaskar Sahu, Shelly Pathania, Nilay Kumar Nandi, Gaurav Chauhan, Vivek Asati, Bhupinder Kumar

Summary: Pyrimidine plays an important role in every step of cell life and has become a crucial pharmacophoric part in medicinal chemistry. It can act as a key pharmacophore in clinically used chemical agents and slight modifications on pyrimidine rings can greatly affect biological activity. This review focuses on the recent developments in pyrimidine-based biologically active molecules and provides valuable information on their structural features and structure activity relationship studies.

JOURNAL OF HETEROCYCLIC CHEMISTRY (2023)

Article Biochemical Research Methods

Design, Synthesis, and Biological Evaluation of Novel Dihydropyrimidinone Derivatives as Potential Anticancer Agents and Tubulin Polymerization Inhibitors

Ramkaran Ramkaran, Ravindra K. K. Rawal, Praveen K. K. Gupta, Bhupinder Kumar, Rohit Bhatia

Summary: The severity and prevalence of cancer in modern time are a huge global health burden. Continuous efforts are being made toward the development of newer therapeutic candidates to treat and manage this ailment. In this study, a series of sixteen dihydropyrimidinone derivatives were synthesized and evaluated for their cytotoxic activity against breast cancer, lung cancer, and colon cancer cell lines. Compounds 5D and 5P showed the most potent cytotoxic activity and better inhibition of tubulin polymerization compared to the standard drug colchicine. Molecular docking analysis revealed significant interactions between compounds 5D and 5P and tubulin, suggesting their potential as leads in drug development against cancer.

ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2023)

Article Biochemistry & Molecular Biology

Design, synthesis of 1,2,4-triazine derivatives as antidepressant and antioxidant agents: In vitro, in vivo and in silico studies

Rohit Pal, Bhupinder Kumar, P. M. Guruubasavaraja Swamy, Pooja A. Chawla

Summary: A series of substituted-N-(5,6-diphenyl-1,2,4-triazin-3-yl) benzamides were designed, synthesized, and evaluated for their antidepressant-like activity. Compound R:5 and R:9 exhibited potent MAO-A inhibition activity and significant antidepressant effects in FST and TST. ADME and docking studies further confirmed their pharmacological characteristics and binding abilities.

BIOORGANIC CHEMISTRY (2023)

Review Biochemistry & Molecular Biology

Rhodanine derivatives: An insight into the synthetic and medicinal perspectives as antimicrobial and antiviral agents

Abhishek Chaurasyia, Pooja Chawla, Vikramdeep Monga, Gurpreet Singh

Summary: Rhodanine and its derivatives are privileged heterocyclic compounds with wide opportunities for structural modification and lead development. They possess diverse biological activities due to their interaction with various protein targets. In recent years, significant progress has been made in developing rhodanine-based antimicrobial and antiviral agents.

CHEMICAL BIOLOGY & DRUG DESIGN (2023)

Review Pharmacology & Pharmacy

An Update on Recently Developed Analytical and Bio-analytical Methods for Some Anticancer Drugs

Joyson Paul, Karanvir Singh, Sumit Pannu, Rohit Pal, Shah Alam Khan, Bhupinder Kumar, Md Jawaid Akhtar

Summary: According to the WHO's data, the global cancer burden reached 18.1 million new cases in 2018, resulting in 9.6 million deaths. Pharmaceutical spending accounts for around 19% of the annual R&D cost to discover new anticancer drugs. However, drug resistance and side effects remain major issues. This review compiles and discusses analytical and bioanalytical methods for anticancer drugs, covering cytotoxic drugs and targeted-based drugs. The accuracy and precision of UV-HPLC, LC-MS, and fluorometry HPLC are examined, along with advanced methods such as Au/Pd@rGO@p(L-Cys) and endophytic fungi for drug production. This review aims to support researchers in overcoming the challenges in drug development.

CURRENT PHARMACEUTICAL ANALYSIS (2023)

Review Chemistry, Medicinal

p53 as a potential target for treatment of cancer: A perspective on recent advancements in small molecules with structural insights and SAR studies

Chahat, Rohit Bhatia, Bhupinder Kumar

Summary: Cancer is a dangerous disease and p53 is a well-researched tumor suppressor protein that plays a critical role in maintaining genetic stability and controlling various cellular processes. Abnormalities in p53 contribute to genetic instability and carcinogenesis. Enhancing p53 activity in cancer cells is a promising anticancer strategy. This article discusses the current advancements in anti-tumor activities targeting p53-MDM2 and emphasizes the structure-activity relationship characteristics (SAR).

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Cell Biology

Role of sodium dependent SLC13 transporter inhibitors in various metabolic disorders

Md Jawaid Akhtar, Shah Alam Khan, Bhupinder Kumar, Pooja Chawla, Rohit Bhatia, Karanvir Singh

Summary: This review discusses the structure, function, and regulation of the NaCT transporter, highlighting the role of citrate in diagnosing diseases such as cancer, diabetes, and fatty liver. The therapeutic potential of synthetic inhibitors against NaCT transporters is also summarized.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2023)

Article Chemistry, Physical

Design, synthesis, pharmacological and in silico screening of disubstituted-piperazine derivatives as selective and reversible MAO-A inhibitors for treatment of depression

Nilay Kumar Nandi, Rohit Bhatia, Suresh Saini, Ravi Rawat, Shilpa Sharma, Khadga Raj, Naresh Rangra, Bhupinder Kumar

Summary: In this study, a series of substituted benzenesulfonyl piperazine derivatives were synthesized and screened for their MAO-A and MAO-B inhibitory activity. Most of the compounds showed selective inhibition of MAO-A isoform. Compound NP4 and NP12 exhibited the strongest MAO-A inhibitory activity and also showed neuroprotective and antioxidant properties.

JOURNAL OF MOLECULAR STRUCTURE (2023)

Review Biochemistry & Molecular Biology

Recent updates on structural insights of MAO-B inhibitors: a review on target-based approach

Gurkaran Singh Baweja, Shankar Gupta, Bhupinder Kumar, Preeti Patel, Vivek Asati

Summary: Parkinson's disease is a neurodegenerative disorder characterized by symptoms such as slow movement, tremors, and stiffness, caused by the loss of dopaminergic neurons in the brain's substantia nigra. The disease is associated with a decrease in dopamine concentration in the brain and can be influenced by genetic and environmental factors. The irregular expression of the MAO-B enzyme, which causes the oxidative deamination of biogenic amines like dopamine, is implicated in Parkinson's disease. Current MAO-B inhibitors have adverse effects, and the development of new inhibitors with minimal side effects is urgently needed. Recent studies have identified potential lead compounds for the development of potent MAO-B inhibitors.

MOLECULAR DIVERSITY (2023)

Article Biochemistry & Molecular Biology

Design, synthesis and biological evaluation of oxadiazole clubbed piperazine derivatives as potential antidepressant agents

Bhaskar Sahu, Rohit Bhatia, Dilpreet Kaur, Diksha Choudhary, Ravi Rawat, Shilpa Sharma, Bhupinder Kumar

Summary: Piperazine derivatives have been synthesized and tested for their MAO inhibitory activity. Compound 5f and 5g showed the strongest potential as MAO-A inhibitors with IC50 values of 0.96 and 0.81 mu M, respectively. These compounds exhibited reversible inhibition of MAO-A without cytotoxicity and displayed good antioxidant activity. In vivo studies demonstrated their antidepressant-like activity. Molecular docking and dynamic studies confirmed the stable complex formation between these compounds and the MAO-A enzyme. These findings suggest that the piperazine clubbed oxadiazole structural framework is a promising target for developing new antidepressant molecules.

BIOORGANIC CHEMISTRY (2023)

Review Pharmacology & Pharmacy

Imidazoles as Serotonin Receptor Modulators for Treatment of Depression: Structural Insights and Structure-Activity Relationship Studies

Kapil Kumar Goel, Somesh Thapliyal, Rajeev Kharb, Gaurav Joshi, Arvind Negi, Bhupinder Kumar

Summary: This article discusses the structure-activity relationship and development overview of imidazole derivatives as antidepressant drugs, as well as their role in modulating the serotonergic system.

PHARMACEUTICS (2023)

Review Biochemistry & Molecular Biology

Peptide Nucleic Acids: Recent Developments in the Synthesis and Backbone Modifications

Gurpreet Singh, Vikramdeep Monga

Summary: Nucleic acids, specifically peptide nucleic acids (PNAs), are ideal drug candidates for protein targets that are difficult to target or develop drugs against. PNAs are synthetic impersonators of nucleic acids and offer a wide range of applications in biotechnology, diagnostics, and potential therapeutics. Various strategies have been explored to modify the polypeptide backbone of PNAs to improve target selectivity and stability in the body.

BIOORGANIC CHEMISTRY (2023)

Article Chemistry, Medicinal

Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection

Shuang Mei, Su Jiang, Yuting Wang, Han Jing, Peng Yang, Miao-Miao Niu, Jindong Li, Kai Yuan, Yan Zhang

Summary: This study identifies a dual-targeting peptide, AP-1, that effectively inhibits variants of concern (VOCs) of SARS-CoV-2 without impairing host cell viability. The findings suggest that AP-1 could be a promising broad-spectrum agent for treating emerging VOCs of SARS-CoV-2.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of proteolysis-targeting chimera targeting undruggable proteins using a covalent ligand screening approach

Hyeonjun Lee, Ju Yeon Lee, Hyunsoo Jang, Hye Young Cho, Minhee Kang, Sang Hyun Bae, Suin Kim, Eunji Kim, Jaebong Jang, Jin Young Kim, Young Ho Jeon

Summary: By using liquid chromatography-tandem mass spectrometry and nuclear magnetic resonance experiments, we identified new chemical moieties that bind to the target sites of the protein of interest, allowing for reversible binding and protein degradation. This method has the potential to expand the application of PROTAC technology.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A pro-death autophagy-based nanoplatform for enhancing antitumour efficacy with improved immune responses

Yingying Li, Xiyou Du, Xinru Kong, Yuelin Fang, Zhijing He, Dongzhu Liu, Hang Wu, Jianbo Ji, Xiaoye Yang, Lei Ye, Guangxi Zhai

Summary: This study proposes a novel nanoplatform based on the autophagy cascade to overcome the obstacles in chemo-immunotherapy. The platform combines chemotherapy and starvation therapy to initiate pro-death autophagy and enhance antigen presentation, while also remodeling the immunosuppressive tumor microenvironment. Furthermore, the study discovers a new therapeutic direction for the respiration inhibitor 3-bromopyruvic acid (3BP) in cancer treatment. Overall, this study offers an opportunity to improve antitumor efficacy and boost immune responses.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A novel scaffold long-acting selective estrogen receptor antagonist and degrader with superior preclinical profile against ER plus breast cancer

Bingsi Wang, Mingxu Ma, Yusen Dai, Pengfei Yu, Liang Ye, Wenyan Wang, Chunjie Sha, Huijie Yang, Yingjie Yang, Yunjing Zhu, Lin Dong, Shujuan Wei, Linlin Wang, Jingwei Tian, Hongbo Wang

Summary: Breast cancer is a common malignant tumor in women, and drug resistance remains a clinical challenge. In this study, a novel compound, G-5b, was developed with potent antagonistic and degradation activities comparable to the current drug fulvestrant. G-5b also showed improved stability and solubility. Mechanistically, G-5b engages the proteasome pathway to degrade ER, inhibiting the ER signaling pathway and inducing apoptosis and cell cycle arrest. In animal models, G-5b exhibited superior pharmacokinetics and pharmacodynamics properties. Overall, G-5b is a promising long-acting SERD worthy of further investigation and optimization.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents

Karoline B. Waitman, Larissa C. de Almeida, Marina C. Primi, Jorge A. E. G. Carlos, Claudia Ruiz, Thales Kronenberger, Stefan Laufer, Marcia Ines Goettert, Antti Poso, Sandra V. Vassiliades, Vinicius A. M. de Souza, Monica F. Z. J. Toledo, Neuza M. A. Hassimotto, Michael D. Cameron, Thomas D. Bannister, Leticia Costa-Lotufo, Joa o A. Machado-Neto, Mauricio T. Tavares, Roberto Parise-Filho

Summary: A series of hybrid inhibitors combining pharmacophores of known kinase inhibitors and benzohydroxamate HDAC inhibitors were synthesized and evaluated for their anticancer activity and pharmacokinetic properties. Compounds 4d-f exhibited promising cytotoxicity against hematological cells and moderate activity against solid tumor models. Compound 4d showed potent inhibition of multiple kinase targets and had stable interactions with HDAC and members of the JAK family. These compounds showed selective cytotoxicity with minimal effects on non-tumorigenic cells and favorable pharmacokinetic profiles.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Unexpected rearrangement of ivermectin in the synthesis of new derivatives with trypanocidal and antiplasmodial activities

Michal Sulik, Diana Fontinha, Dietmar Steverding, Szymon Sobczak, Michal Antoszczak, Miguel Prudencio, Adam Huczynski

Summary: This study describes the synthesis of the first-in-class ivermectin derivatives obtained through derivatization of the C13 position, along with the unexpected rearrangement of the macrolide ring. These derivatives show potential for antiparasitic activity and are important for the development of new antiparasitic agents.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection

Jun Liu, Qiu-Xian Chen, Wen-Fu Wu, Dong Wang, Si -Yu Zhao, Jia-Hao Li, Yi-Qun Chang, Shao-Gao Zeng, Jia-Yi Hu, Yu-Jie Li, Jia-Xin Du, Shu-Meng Jiao, Hai-Chuan Xiao, Qiang Zhang, Jun Xu, Jian-Fu Zhao, Hai -Bo Zhou, Yong-Heng Wang, Jian Zou, Ping-Hua Sun

Summary: A new anti-infective drug strategy has been discovered to attenuate virulence and modulate inflammation caused by drug-resistant Pseudomonas aeruginosa infections. Compound 5f inhibits biofilm formation, macrophage migration, and inflammatory response induced by P. aeruginosa, showing potential as a novel candidate against drug-resistant infections.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Design and synthesis of pterostilbene derivatives bearing triazole moiety that might treat DSS-induced colitis in mice through modulation of NF-KB/ MAPK signaling pathways

Liuzeng Chen, Ke Wang, Lingyun Wang, Wei Wang, Lifan Wang, Jia Li, Xiaohan Liu, Mengya Wang, Banfeng Ruan

Summary: In this study, a series of novel anti-inflammatory compounds were designed and synthesized based on the natural product pterostilbene skeleton. Among them, compound 8 showed the highest activity and exhibited its effects through inhibition of pro-inflammatory cytokines by blocking the NF-KB/MAPK signaling pathway. Compound 8 also demonstrated a good relieving effect on acute colitis in mice and showed good safety in acute toxicity experiments.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of 4-(N-dithiobenzyl piperazine)-1,8-naphthalimide as a potent multi-target antitumor agent with good efficacy, limited toxicity, and low resistance

Si-Min Liang, Gui-Bin Liang, Hui-Ling Wang, Hong Jiang, Xian-Li Ma, Jian-Hua Wei, Ri-Zhen Huang, Ye Zhang

Summary: A series of novel multi-target antitumor agents were designed, synthesized, and evaluated. Some compounds exhibited significant antitumor activity and one compound showed excellent efficacy, limited toxicity, and low resistance. Further mechanism studies revealed that the compound exerted antitumor effects through multiple pathways.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)